Stocks · News reference

8-K filing — ADIAL PHARMACEUTICALS, INC. (ADIL)

Aug 25, 2026, 8:33 PMSEC EDGAR

Filed: 2026-08-25 AccNo: 0001213900-26-093544 Size: 188 KB Item 3.02: Unregistered Sales of Equity Securities

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: edgar
Observed: Aug 25, 2026, 8:33 PM
Checked: Aug 25, 2026, 8:33 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 17, 2026, 4:39 PMBenzinga Newsdesk
Adial Pharmaceuticals shares are trading lower after the company reported a wider net loss for the second quarter.
Read original at benzinga
ADIL
BenzingaAug 17, 2026, 12:00 PMBenzinga Newsdesk
Adial Pharmaceuticals Q2 EPS $(11.25)
Read original at benzinga
ADIL
BenzingaAug 13, 2026, 9:30 PMBenzinga Newsdesk
Adial Pharmaceuticals Says As Of Aug 10, Anticipates Termination Of CEO Cary Claiborne After 2026 Annual Meeting; Anticipates Matthew Davidson To Be Appointed President And CEO; Anticipates Termination Of CFO Vinay Shah After 2026 Annual Meeting; Anticipates Board Changes And Legacy Member Resignations
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As of August 10, 2026, Adial Pharmaceuticals, Inc. (the
Read original at benzinga
ADIL